1. Kim, Yona, You, Ji Hyeon, Ryu, Yeonjoo, Park, Sung-Hye, Paek, Sun Ha. 2024. ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma. In NPJ precision oncology, 8, 79. doi:10.1038/s41698-024-00566-1. https://pubmed.ncbi.nlm.nih.gov/38548861/
2. Selinger, Martin, Věchtová, Pavlína, Tykalová, Hana, Štěrba, Ján, Grubhoffer, Libor. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. In Computational and structural biotechnology journal, 20, 2759-2777. doi:10.1016/j.csbj.2022.05.052. https://pubmed.ncbi.nlm.nih.gov/35685361/
3. Dorrity, Tyler J, Shin, Heegwon, Wiegand, Kenenni A, Wichterle, Hynek, Chung, Hachung. 2023. Long 3'UTRs predispose neurons to inflammation by promoting immunostimulatory double-stranded RNA formation. In Science immunology, 8, eadg2979. doi:10.1126/sciimmunol.adg2979. https://pubmed.ncbi.nlm.nih.gov/37862432/
4. Kato, Yuzuru, Iwamori, Tokuko, Ninomiya, Youichirou, Sato, Mikiko, Saga, Yumiko. 2019. ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles. In EMBO reports, 20, e48251. doi:10.15252/embr.201948251. https://pubmed.ncbi.nlm.nih.gov/31657143/
5. Berto, Stefano, Usui, Noriyoshi, Konopka, Genevieve, Fogel, Brent L. 2016. ELAVL2-regulated transcriptional and splicing networks in human neurons link neurodevelopment and autism. In Human molecular genetics, 25, 2451-2464. doi:. https://pubmed.ncbi.nlm.nih.gov/27260404/
6. Heddar, Abdelkader, Ogur, Cagri, Da Costa, Sabrina, Catteau-Jonard, Sophie, Misrahi, Micheline. 2022. Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. In EBioMedicine, 84, 104246. doi:10.1016/j.ebiom.2022.104246. https://pubmed.ncbi.nlm.nih.gov/36099812/
7. Park, Ga Bin, Jeong, Jee-Yeong, Choi, Sangbong, Yoon, Yoo Sang, Kim, Daejin. . Glucose deprivation enhances resistance to paclitaxel via ELAVL2/4-mediated modification of glycolysis in ovarian cancer cells. In Anti-cancer drugs, 33, e370-e380. doi:10.1097/CAD.0000000000001215. https://pubmed.ncbi.nlm.nih.gov/34419957/